Terms: = Thyroid cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Diagnosis
5249 results:
1. Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of thyroid cancer.
Fu G; Chazen RS; MacMillan C; Witterick IJ
JAMA Netw Open; 2024 May; 7(5):e2411919. PubMed ID: 38758552
[TBL] [Abstract] [Full Text] [Related]
2. [Imaging characteristics and diagnosis of primary middle mediastinal tumors].
Chen JQ; Wang JW
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):449-456. PubMed ID: 38742358
[No Abstract] [Full Text] [Related]
3.
Zang Z; Yin Y; Liu C; Zhu Q; Huang X; Li H; Yang R
Epigenetics; 2024 Dec; 19(1):2352683. PubMed ID: 38723244
[TBL] [Abstract] [Full Text] [Related]
4. Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease.
Park J; An S; Bae JS; Kim JS; Kim K
Front Endocrinol (Lausanne); 2024; 15():1382124. PubMed ID: 38711981
[TBL] [Abstract] [Full Text] [Related]
5. Differential diagnosis of thyroid nodules using heterogeneity quantification software on ultrasound images: correlation with the Bethesda system and surgical pathology.
Ryu YJ; Kim JW; Park SC; Hur YH; Kim HJ; Kim TH
Sci Rep; 2024 May; 14(1):10288. PubMed ID: 38704392
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic Value of Immunostaining for thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
Ji N; Lee Y; Lee SH; Kim HS
Anticancer Res; 2024 May; 44(5):2159-2170. PubMed ID: 38677751
[TBL] [Abstract] [Full Text] [Related]
7. Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels-A retrospective analysis from the UK Acromegaly Register 1970-2016.
Orme S; McNally R; James PW; Davis J; Ayuk J; Higham C; Wass J;
Clin Endocrinol (Oxf); 2024 Jun; 100(6):558-564. PubMed ID: 38652736
[TBL] [Abstract] [Full Text] [Related]
8. Ultrasound and cytopathological characteristics of thyroid tumours of uncertain malignant potential - from diagnosis to treatment.
Żyłka A; Dobruch-Sobczak K; Piotrzkowska-Wróblewska H; Jędrzejczyk M; Góralski P; Gałczyński J; Bakuła-Zalewska E; Dedecjus M
Endokrynol Pol; 2024; 75(2):170-178. PubMed ID: 38646986
[TBL] [Abstract] [Full Text] [Related]
9. Association between Consumption of Iodine-Rich Foods and thyroid cancer Prevalence: Findings from a Large Population-Based Study.
Kwon YJ; Lee HS; Kang SW; Lee JW
Nutrients; 2024 Apr; 16(7):. PubMed ID: 38613074
[TBL] [Abstract] [Full Text] [Related]
10. Tumor growth manifested in two-fifths of low-risk papillary thyroid microcarcinoma patients during active surveillance: data from a tertiary center in China.
Le K; Jin L; Zhong F; Huang X; Zhou L; Zhou J; Xie L
Front Endocrinol (Lausanne); 2024; 15():1359621. PubMed ID: 38577570
[TBL] [Abstract] [Full Text] [Related]
11. [Non-primary solid malignancies of breast in needle core biopsy: a clinicopathological analysis of 23 cases].
Gu WQ; Wang L; Xu JC; Ping GQ; Han X; Wang C
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):331-336. PubMed ID: 38556815
[No Abstract] [Full Text] [Related]
12. Diagnostic utilities of washout CYFRA 21-1 combined with washout thyroglobulin for metastatic lymph nodes in thyroid cancer: a prospective study.
Park J; An S; Kim K; Kim JS; Jung CK; Bae JS
Sci Rep; 2024 Mar; 14(1):7599. PubMed ID: 38556517
[TBL] [Abstract] [Full Text] [Related]
13. A comparison of the WHO 2004 and WHO 2017 thyroid tumor classifications.
Patel N; Bavikar R; Lad YP; Singh M; Dharwadkar A; Viswanathan V
J Cancer Res Ther; 2024 Jan; 20(1):311-314. PubMed ID: 38554339
[TBL] [Abstract] [Full Text] [Related]
14. thyroid cancer Survival in the Multiethnic Cohort Study.
Abe JV; Park SY; Haiman CA; Cheng I; Le Marchand L; Hernandez BY; Wilkens LR
Int J Environ Res Public Health; 2024 Mar; 21(3):. PubMed ID: 38541323
[TBL] [Abstract] [Full Text] [Related]
15. Primary thyroid Lymphoma: A Retrospective-Observational Study in a Single Institutional Center.
Vita O; Dema A; Barna R; Cornea R; Brebu D; Vlad M; Popa O; Muntean I; Szilagyi D; Iacob M; Iordache M; Cornianu M; Lazureanu DC
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541203
[No Abstract] [Full Text] [Related]
16. Multimodal ultrasonography evaluation in thyroid nodule characterization: what is the ideal algorithm?
Gürsel BE; Çağlar B; Özpar R; Saraydaroğlu Ö; Gökalp G; Topal NB
Med Ultrason; 2024 Mar; 26(1):41-49. PubMed ID: 38537188
[TBL] [Abstract] [Full Text] [Related]
17. Sonographic characteristics of diffuse sclerosing variant of papillary thyroid carcinoma with histopathological correlation: a preliminary study.
Li W; Wang Y; Gao L; Feng R; Lv K; Wu X; Yang X; Cai S; Wang H; Li J
Orphanet J Rare Dis; 2024 Mar; 19(1):136. PubMed ID: 38532506
[TBL] [Abstract] [Full Text] [Related]
18. Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients.
Ghossein R; Katabi N; Dogan S; Shaha AR; Tuttle RM; Fagin JA; Ganly I; Xu B
Histopathology; 2024 Jun; 84(7):1130-1138. PubMed ID: 38528726
[TBL] [Abstract] [Full Text] [Related]
19. Consistency between the National Patient Register and the Swedish cancer Register.
Sakakibara S; Pazzagli L; Linder M
Pharmacoepidemiol Drug Saf; 2024 Apr; 33(4):e5780. PubMed ID: 38511251
[TBL] [Abstract] [Full Text] [Related]
20. The potential value of ultrasound in predicting local refractory/relapse events in primary thyroid lymphoma patients.
Ji J; Gao L; Liu R; Shi X; Ma L; Pan A; Li N; Liu C; Li X; Yang M; Xia Y; Jiang Y
Cancer Imaging; 2024 Mar; 24(1):39. PubMed ID: 38509603
[TBL] [Abstract] [Full Text] [Related]
[Next]